Cooper Companies (COO) Current Deferred Revenue (2021 - 2026)
Cooper Companies (COO) posted Current Deferred Revenue of $127.9 million for Q2 2026, down 1.54% on a QoQ basis from $129.9 million in Q1 2026, and little changed year-over-year from $127.6 million in Q2 2025.
Analysis
Cooper Companies (COO) Current Deferred Revenue (2021 - 2026) Analysis & Trends
Cooper Companies has reported Current Deferred Revenue for 6 years, with the latest figure at $127.9 million in Q2 2026.
- On a quarterly basis, Current Deferred Revenue changed 0.24% year-over-year to $127.9 million in Q2 2026; TTM through Apr 2026 was $127.9 million, a 0.24% change from a year earlier, with the FY2025 full-year figure at $127.9 million, down 1.54% from the prior year.
- Current Deferred Revenue was $127.9 million for Q2 2026 at Cooper Companies, down from $129.9 million in the prior quarter.
- The five-year high for Current Deferred Revenue was $129.9 million in Q4 2024, with the low at $93.6 million in Q4 2022.
- Average Current Deferred Revenue over 5 years is $122.2 million, with a median of $126.3 million recorded in 2025.
- The sharpest annual moves came in 2022 and 2025: Current Deferred Revenue surged 392.63% in 2022, then slipped 1.54% in 2025.
- Over 5 years, Current Deferred Revenue stood at $93.6 million in 2022, then surged by 32.05% to $123.6 million in 2023, then rose by 5.1% to $129.9 million in 2024, then dropped by 1.54% to $127.9 million in 2025, then changed by 0.0% to $127.9 million in 2026.
- The last three Current Deferred Revenue figures came in at $127.9 million (Q2 2026), $129.9 million (Q1 2026), and $127.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn |
| 10 | Cooper Companies | 10.51 Bn | 10.37 Bn | 735.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 127.90 Mn |
| Jan 31, 2026 | 129.90 Mn |
| Oct 31, 2025 | 127.90 Mn |
| Jul 31, 2025 | 126.60 Mn |
| Apr 30, 2025 | 127.60 Mn |
| Jan 31, 2025 | 126.30 Mn |
| Oct 31, 2024 | 129.90 Mn |
| Jul 31, 2024 | 126.40 Mn |
| Apr 30, 2024 | 121.70 Mn |
| Jan 31, 2024 | 122.40 Mn |
| Oct 31, 2023 | 123.60 Mn |
| Jul 31, 2023 | 122.80 Mn |
| Apr 30, 2023 | 119.70 Mn |
| Jan 31, 2023 | 106.40 Mn |
| Oct 31, 2022 | 93.60 Mn |
| Oct 31, 2021 | 19.00 Mn |